Cocrystal Pharma, Inc. Quarterly Weighted Average Number of Shares Outstanding, Diluted from Q1 2011 to Q3 2024

Taxonomy & unit
us-gaap: shares
Description
The average number of shares or units issued and outstanding that are used in calculating diluted EPS or earnings per unit (EPU), determined based on the timing of issuance of shares or units in the period.
Summary
Cocrystal Pharma, Inc. quarterly/annual Weighted Average Number of Shares Outstanding, Diluted history and growth rate from Q1 2011 to Q3 2024.
  • Cocrystal Pharma, Inc. Weighted Average Number of Shares Outstanding, Diluted for the quarter ending September 30, 2024 was 10.2M shares, a 0.21% increase year-over-year.
  • Cocrystal Pharma, Inc. annual Weighted Average Number of Shares Outstanding, Diluted for 2023 was 9.65M shares, a 18.5% increase from 2022.
  • Cocrystal Pharma, Inc. annual Weighted Average Number of Shares Outstanding, Diluted for 2022 was 8.14M shares.
  • Cocrystal Pharma, Inc. annual Weighted Average Number of Shares Outstanding, Diluted for 2017 was 24.1M shares, a 2.52% increase from 2016.
Weighted Average Number of Shares Outstanding, Diluted, Quarterly (shares)
Weighted Average Number of Shares Outstanding, Diluted, YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q3 2024 10.2M +21K +0.21% Jul 1, 2024 Sep 30, 2024 10-Q 2024-11-13
Q2 2024 10.2M +109K +1.08% Apr 1, 2024 Jun 30, 2024 10-Q 2024-08-14
Q1 2024 10.2M +2.03M +24.9% Jan 1, 2024 Mar 31, 2024 10-Q 2024-05-13
Q4 2023 9.65M Oct 1, 2023 Dec 31, 2023 10-K 2024-03-28
Q3 2023 10.2M +2.01M +24.7% Jul 1, 2023 Sep 30, 2023 10-Q 2024-11-13
Q2 2023 10.1M +1.92M +23.6% Apr 1, 2023 Jun 30, 2023 10-Q 2024-08-14
Q1 2023 8.14M Jan 1, 2023 Mar 31, 2023 10-Q 2024-05-13
Q3 2022 8.14M Jul 1, 2022 Sep 30, 2022 10-Q 2023-11-13
Q2 2022 8.14M Apr 1, 2022 Jun 30, 2022 10-Q 2023-08-14
Q1 2021 71.3M +29.6M +71.1% Jan 1, 2021 Mar 31, 2021 10-Q 2021-05-17
Q2 2020 52.1M +20.5M +64.9% Apr 1, 2020 Jun 30, 2020 10-Q 2020-08-06
Q1 2020 41.7M +11.3M +37.2% Jan 1, 2020 Mar 31, 2020 10-Q 2021-05-17
Q3 2019 31.6M +1.7M +5.68% Jul 1, 2019 Sep 30, 2019 10-Q 2019-11-12
Q2 2019 31.6M +3.91M +14.1% Apr 1, 2019 Jun 30, 2019 10-Q 2020-08-06
Q1 2019 30.4M +5.99M +24.6% Jan 1, 2019 Mar 31, 2019 10-Q 2020-05-13
Q3 2018 29.9M -698M -95.9% Jul 1, 2018 Sep 30, 2018 10-Q 2019-11-12
Q2 2018 27.7M +3.45M +14.2% Apr 1, 2018 Jun 30, 2018 10-Q 2019-08-09
Q1 2018 24.4M +583K +2.45% Jan 1, 2018 Mar 31, 2018 10-Q 2019-05-10
Q4 2017 24.1M +593K +2.52% Oct 1, 2017 Dec 31, 2017 10-K 2018-03-21
Q3 2017 728M +20.6M +2.91% Jul 1, 2017 Sep 30, 2017 10-Q 2017-11-08
Q2 2017 24.3M -681M -96.6% Apr 1, 2017 Jun 30, 2017 10-Q 2018-11-09
Q1 2017 23.8M -673M -96.6% Jan 1, 2017 Mar 31, 2017 10-Q 2018-05-10
Q4 2016 23.5M +2.52M +12% Oct 1, 2016 Dec 31, 2016 10-K 2018-03-21
Q3 2016 707M +707M +101411% Jul 1, 2016 Sep 30, 2016 10-Q 2017-11-08
Q2 2016 706M +705M +101170% Apr 1, 2016 Jun 30, 2016 10-Q 2017-08-08
Q1 2016 697M +697M +158410% Jan 1, 2016 Mar 31, 2016 10-Q 2017-05-10
Q4 2015 21M -307M -93.6% Oct 1, 2015 Dec 31, 2015 10-K 2018-03-21
Q3 2015 697K +370K +113% Jul 1, 2015 Sep 30, 2015 10-Q 2016-11-09
Q2 2015 697K +370K +113% Apr 1, 2015 Jun 30, 2015 10-Q 2016-08-09
Q1 2015 440K +115K +35.6% Jan 1, 2015 Mar 31, 2015 10-Q 2016-05-10
Q4 2014 328M +328M +572344% Oct 1, 2014 Dec 31, 2014 10-K 2017-03-31
Q3 2014 327K -69.8M -99.5% Jul 1, 2014 Sep 30, 2014 10-Q 2015-11-16
Q2 2014 327K +270K +471% Apr 1, 2014 Jun 30, 2014 10-Q 2015-08-14
Q1 2014 324K +267K +467% Jan 1, 2014 Mar 31, 2014 10-Q 2014-05-15
Q4 2013 57.3K -61.6M -99.9% Oct 1, 2013 Dec 31, 2013 10-K 2015-03-31
Q3 2013 70.1M +680K +0.98% Jul 1, 2013 Sep 30, 2013 10-Q 2013-11-18
Q2 2013 57.3K -59M -99.9% Apr 1, 2013 Jun 30, 2013 10-Q 2014-08-14
Q1 2013 57.3K -56.3M -99.9% Jan 1, 2013 Mar 31, 2013 10-Q 2014-05-15
Q4 2012 61.6M +11.2M +22.2% Oct 1, 2012 Dec 31, 2012 10-K 2014-03-31
Q3 2012 69.4M +1.93M +2.85% Jul 1, 2012 Sep 30, 2012 10-Q 2013-11-18
Q2 2012 59.1M +17.7M +42.8% Apr 1, 2012 Jun 30, 2012 10-Q 2013-08-15
Q1 2012 56.4M +11.6M +26% Jan 1, 2012 Mar 31, 2012 10-Q 2013-05-10
Q4 2011 50.4M Oct 1, 2011 Dec 31, 2011 10-K 2013-04-01
Q3 2011 67.5M Jul 1, 2011 Sep 30, 2011 10-Q 2012-11-14
Q2 2011 41.4M Apr 1, 2011 Jun 30, 2011 10-Q/A 2012-09-28
Q1 2011 44.7M Jan 1, 2011 Mar 31, 2011 10-Q/A 2012-10-02
* An asterisk sign (*) next to the value indicates that the value is likely invalid.